Advanced Proteome Therapeutics Corp. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Advanced Proteome Therapeutics Corp.

Advanced Proteome Therapeutics Corp.

Advanced Proteome Therapeutics Corp.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	126.69 M
Public Float	-

Advanced Proteome Therapeutics Corp.
Stock Exchange	Toronto Ventures Stock Exchange
EPS	CAD0.04
Market Cap	CAD3.15 M
Shares Outstanding	19.92 M
Public Float	-

Profile

Address	BioSquare Boston Massachusetts 02118 United States
Employees	-
Website	http://www.advancedproteome.com
Updated	07/08/2019
Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development of anti-cancer therapeutics. It also commercializes technology platform that is intended for the chemical modification of protein therapeutics. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Boston, MA.

Financials

Key People

William H. Dickie

President, Chief Executive Officer & Director

Alexander Krantz

COO, Secretary, Non-Executive Director & CSO